Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin

Lung cancer accounts for the highest percentage of cancer morbidity and mortality worldwide, and lung adenocarcinoma (LUAD) is the most prevalent subtype. Although numerous therapies have been developed for lung cancer, patient prognosis is limited by tumor metastasis and more effective treatment ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanyi, Zhang, Ting, Du, Hongfei, Yang, Min, Xie, Guangsu, Liu, Teng, Deng, Shihua, Yuan, Wei, He, Shuang, Wu, Dongming, Xu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360146/
https://www.ncbi.nlm.nih.gov/pubmed/37449493
http://dx.doi.org/10.3892/or.2023.8598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360146/
https://www.ncbi.nlm.nih.gov/pubmed/37449493
http://dx.doi.org/10.3892/or.2023.8598

Ejemplares similares